PA8561001A1 - Derivados del 7-amino-benzotiazol - Google Patents
Derivados del 7-amino-benzotiazolInfo
- Publication number
- PA8561001A1 PA8561001A1 PA20028561001A PA8561001A PA8561001A1 PA 8561001 A1 PA8561001 A1 PA 8561001A1 PA 20028561001 A PA20028561001 A PA 20028561001A PA 8561001 A PA8561001 A PA 8561001A PA 8561001 A1 PA8561001 A1 PA 8561001A1
- Authority
- PA
- Panama
- Prior art keywords
- ilo
- rent
- optionally substituted
- lower rent
- morfolinilo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE FORMULA GENERAL I EN DONDE R1,R2 SON INDEPENDIENTEMENTE ENTRE SI, HIDROGENO, ALQUILO INFERIOR, CICLOALQUILO DE 3 A 6 ATOMOS DE CARBONO, TETRAHIDROPIRAN-2,3 O 4-ILO, PIPERIDIN-4-ILO, OPCIONALMENTE SUBSTITUIDOS CON ALQUILO INFERIOR, -(CH2)N-O-ALQUILO INFERIOR, -(CH2)N-NR´R´´, -C(O)-ALQUILO INFERIOR,-(CH2)N-C(O)-ALQUILO INFERIOR, -(CH2)N-C(O)-CICLOALQUILO DE 3 A 6 ATOMOS DE CARBONO, -(CH2)N-C(O)-NR´R´´,-(CH2)N-FENILO, OPCIONALMENTE SUBSTITUIDOS CON ALQUILO INFERIOR, ALCOXILO INFERIOR O NR´R´´ O ES -(CH2)N-PIRIDINILO, OPCIONALMENTE SUBSTITUIDO CON ALQUILO INFERIOR, ALCOXILO INFERIOR O NR´R´´, O ES -(CH2)N-MORFOLINILO, -(CH2)N-TETRAHIDROPIRAN-2,3 O 4-ILO, -(CH2)N-PIPERIDIN-1 O 4-ILO, OPCIONALMENTE SUBSTITUIDOS CON ALQUILO INFERIOR, O ES -C(O)-C5,6-CICLOALQUILO, -C(O)-TETRAHIDROPIRAN-2,3 O 4-ILO, -C(O)-MORFOLINILO, -C(O)-PIPERIDIN-1-ILO O -C(O)-PIPERIDIN-1-ILO O -C(O)-PIRROLIDIN-1-ILO, O R1 Y R2 FORMAN JUNTAMENTE CON EL ATOMO DE N AL CUAL ESTAN UNIDOS, EL ANILLO 2-OXA-5-AZA-BICICLO[2.2.1]HEPT-5-ILO O UN ANILLO AZETIDINILO, OPCIONALMENTE SUBSTITUIDO CON ALQUILO INFERIOR O ALCOXILO INFERIOR; ES ALCOXILO INFERIOR, FENILO OPCIONALMENTE SUBSTITUIDO CON HALOGENO, -CH2)N-HALOGENO, O CON -(CH2)N-N(R')-(CH2)N+1-O-ALQUILO INFERIOR, O ES PIRIDINILO, OPCIONALMENTE SUBSTITUIDO CON ALQUILO INFERIOR, HALOGENO O CON MORFOLINILO O ES MORFOLINILO, PIPERIDIN-1-ILO, DISUBSTITUIDO EN LA POSICION 4 CON ALQUILO INFERIOR Y -(CH2)N-OH, O ES 2-AZA-BICICLO[2.2.2]OCTANO; N ES 1 O 2; R´/R´´ SON INDEPENDIENTEMENTE ENTRE SI, HIDROGENO O ALQUILO INFERIOR O JUNTAMENTE PUEDEN FORMAR CON EL ATOMO DE N UN GRUPO AZETIDINILO, PIRROLIDINILO O PIPERIDINILO; Y A LAS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS. SE HA DESCUBIERTO QUE LOS COMPUESTOS DE FORMULA GENERAL I SON LIGANDOS DEL RECEPTOR DE LA ADENOSINA. ESPECIFICAMENTE, LOS COMPUESTOS DE LA PRESENTE INVENCION TIENEN UNA BUENA AFINIDAD PARA EL RECEPTOR A2A Y SON POR LO TANTO DE UTILIDAD EN EL TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON ESTE RECEPTOR.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01129272 | 2001-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8561001A1 true PA8561001A1 (es) | 2003-12-10 |
Family
ID=8179486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20028561001A PA8561001A1 (es) | 2001-12-12 | 2002-12-10 | Derivados del 7-amino-benzotiazol |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6713499B2 (es) |
| EP (1) | EP1456188A1 (es) |
| JP (1) | JP4244189B2 (es) |
| KR (1) | KR100581705B1 (es) |
| CN (1) | CN1305862C (es) |
| AR (1) | AR037767A1 (es) |
| AU (1) | AU2002360960B8 (es) |
| BR (1) | BR0214884A (es) |
| CA (1) | CA2469884A1 (es) |
| GT (1) | GT200200269A (es) |
| MX (1) | MXPA04005633A (es) |
| PA (1) | PA8561001A1 (es) |
| PE (1) | PE20030761A1 (es) |
| PL (1) | PL373953A1 (es) |
| RU (1) | RU2299203C2 (es) |
| TW (1) | TW200409763A (es) |
| UY (1) | UY27580A1 (es) |
| WO (1) | WO2003053946A1 (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6734179B2 (en) * | 2001-12-12 | 2004-05-11 | Hoffmann-La Roche Inc. | Benzothiazoles |
| MXPA05012369A (es) | 2003-05-21 | 2006-02-02 | Hoffmann La Roche | Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina. |
| KR20060058132A (ko) | 2003-09-19 | 2006-05-29 | 에프. 호프만-라 로슈 아게 | 아데노신 수용체 리간드로서의 싸이아졸로피리딘 유도체 |
| TW200524887A (en) * | 2003-10-27 | 2005-08-01 | Lundbeck & Co As H | N-thiazol-2-yl-benzamide derivatives |
| EP1677791A4 (en) * | 2003-10-31 | 2007-08-15 | Takeda Pharmaceutical | NITROGENIC CONDENSED HETEROCYCLIC COMPOUNDS |
| PL1753760T3 (pl) * | 2004-05-24 | 2008-06-30 | Hoffmann La Roche | (4-metoksy-7-morffolin-4-ylobenzatiazol-2-ilo)amid kwasu 4-hydroksy-4-metylopiperydyno-1-karboksylowego |
| KR100834179B1 (ko) * | 2004-05-24 | 2008-05-30 | 에프. 호프만-라 로슈 아게 | 4-하이드록시-4-메틸-피페리딘-1-카복실산(4-메톡시-7-모폴린-4-일-벤조티아졸-2-일)-아마이드 |
| CA2574180A1 (en) * | 2004-07-22 | 2006-01-26 | F. Hoffmann-La Roche Ag | Substituted benzothiazoles |
| AU2005263500B2 (en) | 2004-07-22 | 2011-02-24 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives |
| AU2005287729A1 (en) | 2004-09-22 | 2006-03-30 | H. Lundbeck A/S | 2-acylaminothiazole derivatives |
| US8604055B2 (en) * | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
| KR101238525B1 (ko) * | 2004-12-31 | 2013-02-28 | 레디 유에스 테라퓨틱스 인코포레이티드 | Ｃｅｔｐ 저해제로서의 신규 벤질아민 유도체 |
| BRPI0609719B8 (pt) | 2005-03-23 | 2021-05-25 | Hoffmann La Roche | derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2 |
| US7674912B2 (en) | 2005-04-25 | 2010-03-09 | H. Lundbeck A/S | Pro-drugs of N-thiazol-2-yl-benzamide derivatives |
| BRPI0616571A2 (pt) | 2005-09-27 | 2011-06-21 | Hoffmann La Roche | oxadiazolil pirazol-piridiminas como antagonistas de mglur2, processo para sua preparação, composição farmacêutica que os contém e uso dos mesmo |
| ES2350013T3 (es) | 2006-05-18 | 2011-01-14 | F. Hoffmann-La Roche Ag | Derivados de tiazolo-pirimidina/piridina-urea como antagonistas de receptor de adenosina a2b. |
| US8168785B2 (en) | 2009-06-17 | 2012-05-01 | Biotie Therapies, Inc. | Benzothiazole derivatives |
| RU2448100C1 (ru) * | 2010-09-24 | 2012-04-20 | Татьяна Николаевна Иванова | Производные 2-аминобензотиазола, обладающие противогипоксической активностью, и способ их использования |
| DE102011005232A1 (de) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosin und seine Derivate zur Verwendung in der Schmerztherapie |
| CA2845284C (en) | 2011-08-18 | 2018-03-06 | Dr. Reddy's Laboratories Ltd. | Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors |
| KR101803866B1 (ko) | 2011-09-27 | 2017-12-04 | 닥터 레디스 레보러터리즈 리미티드 | 동맥경화증 치료에 유용한 콜레스테릴 에스테르-전달 단백질(cetp) 억제제로서 5-벤질아미노메틸-6-아미노피라졸로[3,4-b]피리딘 유도체 |
| WO2017136375A1 (en) * | 2016-02-05 | 2017-08-10 | Concert Pharmaceuticals, Inc. | Deuterated tozadenant |
| SG11202000823WA (en) * | 2017-08-01 | 2020-02-27 | Merck Patent Gmbh | Thiazolopyridine derivatives as adenosine receptor antagonists |
| DE102019110904B4 (de) | 2019-04-26 | 2022-01-20 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1117663A2 (en) * | 1998-09-30 | 2001-07-25 | Neurogen Corporation | 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| KR100571161B1 (ko) * | 2000-06-21 | 2006-04-17 | 에프. 호프만-라 로슈 아게 | 벤조티아졸 유도체 |
-
2002
- 2002-12-02 US US10/307,702 patent/US6713499B2/en not_active Expired - Fee Related
- 2002-12-05 WO PCT/EP2002/013770 patent/WO2003053946A1/en active Application Filing
- 2002-12-05 BR BR0214884-6A patent/BR0214884A/pt not_active Application Discontinuation
- 2002-12-05 JP JP2003554662A patent/JP4244189B2/ja not_active Expired - Fee Related
- 2002-12-05 MX MXPA04005633A patent/MXPA04005633A/es active IP Right Grant
- 2002-12-05 PL PL02373953A patent/PL373953A1/xx not_active Application Discontinuation
- 2002-12-05 AU AU2002360960A patent/AU2002360960B8/en not_active Ceased
- 2002-12-05 KR KR1020047008929A patent/KR100581705B1/ko not_active IP Right Cessation
- 2002-12-05 CN CNB028250095A patent/CN1305862C/zh not_active Expired - Fee Related
- 2002-12-05 CA CA002469884A patent/CA2469884A1/en not_active Abandoned
- 2002-12-05 RU RU2004121688/04A patent/RU2299203C2/ru not_active IP Right Cessation
- 2002-12-05 EP EP02795100A patent/EP1456188A1/en not_active Withdrawn
- 2002-12-09 TW TW091135543A patent/TW200409763A/zh unknown
- 2002-12-10 AR ARP020104772A patent/AR037767A1/es unknown
- 2002-12-10 PA PA20028561001A patent/PA8561001A1/es unknown
- 2002-12-11 PE PE2002001192A patent/PE20030761A1/es not_active Application Discontinuation
- 2002-12-11 GT GT200200269A patent/GT200200269A/es unknown
- 2002-12-11 UY UY27580A patent/UY27580A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0214884A (pt) | 2004-11-23 |
| AU2002360960A1 (en) | 2003-07-09 |
| CA2469884A1 (en) | 2003-07-03 |
| CN1604897A (zh) | 2005-04-06 |
| KR20040073472A (ko) | 2004-08-19 |
| EP1456188A1 (en) | 2004-09-15 |
| MXPA04005633A (es) | 2004-12-06 |
| GT200200269A (es) | 2003-07-30 |
| UY27580A1 (es) | 2003-06-30 |
| JP4244189B2 (ja) | 2009-03-25 |
| CN1305862C (zh) | 2007-03-21 |
| RU2004121688A (ru) | 2005-05-27 |
| RU2299203C2 (ru) | 2007-05-20 |
| AU2002360960B8 (en) | 2008-04-10 |
| JP2005526706A (ja) | 2005-09-08 |
| US6713499B2 (en) | 2004-03-30 |
| AR037767A1 (es) | 2004-12-01 |
| AU2002360960B2 (en) | 2008-03-06 |
| US20030153566A1 (en) | 2003-08-14 |
| TW200409763A (en) | 2004-06-16 |
| PL373953A1 (en) | 2005-09-19 |
| PE20030761A1 (es) | 2003-09-05 |
| KR100581705B1 (ko) | 2006-05-22 |
| WO2003053946A1 (en) | 2003-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8561001A1 (es) | Derivados del 7-amino-benzotiazol | |
| US10472371B2 (en) | Compositions for activating pyruvate kinase | |
| PA8558001A1 (es) | Derivados de isonicotin y nicotinamida de benzotiazoles | |
| PE20030349A1 (es) | Derivados de 4-amino-6-fenil-pirrolo[2,3-d]pirimidina como inhibidores de tirosin cinasas | |
| PE20060531A1 (es) | Derivados de piridazin-3-(2h)-ona como inhibidores de la fosfodiesterasa 4 | |
| BR0016282A (pt) | Inibidores de caspase e usos destes | |
| PE20050074A1 (es) | Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante | |
| CO6160237A2 (es) | Pirazinonas y pirazinoles sustituidos y composiciones que los comprenden | |
| AR037680A1 (es) | Antagonistas del receptor de adenosina a2a de 5-amino-pirazolo-[4,3-e]-1,2,4-triazolo[1,5-c]-pirimidinas sustituidas, composiciones farmaceuticas que los comprenden, el uso de dichos compuestos, solos o en combinacion para la elaboracion de un medicamento utiles para el tratamiento de enfermedades d | |
| DK0550113T3 (da) | Triazolpyrimidinderivater med fungicid virkning | |
| PE20030129A1 (es) | Imidazotriazinas | |
| IL194570A (en) | Converted pyrazolopyrimidine compounds | |
| YU61192A (sh) | Imidazo(2,1-b)(3)benzazepinski derivati i preparati | |
| CY1106012T1 (el) | Thieno[2,3-d]pyrimidines με συνδυασμενη αγωνιστικη δραστηριοτητα της ωχρινοτροπου (lh) και της ωοθυλακιοτροπου (fsh) ορμονης | |
| ATE424393T1 (de) | 3-substituierte 4-pyrimidonderivate | |
| RU2011108495A (ru) | Конденсированное гетероциклическое соединение | |
| EA200800403A1 (ru) | Производные n-(гетероарил)-1-гетероарилалкил-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
| Burbiel et al. | 2‐Amino [1, 2, 4] triazolo [1, 5‐c] quinazolines and Derived Novel Heterocycles: Syntheses and Structure–Activity Relationships of Potent Adenosine Receptor Antagonists | |
| HUP0402324A2 (hu) | [1,2,4]-Triazolo[1,5-a]piridin- és [1,2,4]triazolo[1,5-c]pirimidin-származékok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények | |
| EA200000526A1 (ru) | Комбинация, эффективная для лечения импотенции | |
| ATE297901T1 (de) | Kondensierte imidazolderivate | |
| EA202190323A1 (ru) | ИМИДАЗО[1,2-b]ПИРИДАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ Trk | |
| EP4161494A1 (en) | Nitrogen-containing fused bicyclic compounds and their use as ubiquitin-specific-processing protease 1 (usp1) inhibitors | |
| Gamage et al. | Synthesis and biological evaluation of sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474 | |
| WO2006111662A3 (fr) | Derives de 4h-1 , 2 , 4-triazin-5-0nes , leur preparation et leur utilisation comme des recepteurs a l'acetylcholine de type nicotiniques alpha7 |